Related Experiment Video
Updated: Sep 12, 2025

Inducing Meningococcal Meningitis Serogroup C in Mice via Intracisternal Delivery
Published on: November 5, 2019
Vaccination Against Meningococcal Disease in Children-A European Perspective
Lisbeth M Næss1, Sara V Watle2
1Department of Infection Control and Vaccines, Division of Infection Control, Norwegian Institute of Public Health, Oslo, Norway.
Abstract:
Invasive meningococcal disease (IMD) is a severe disease caused by the bacterium Neisseria meningitidis. The highest incidence is seen in children. The epidemiology of IMD is unpredictable and varies over time by country, age and serogroup, and IMD surveillance is pivotal for vaccine recommendations. The incidence of IMD has declined in recent years, partly due to vaccination, but some countries like France are experiencing the highest case numbers in years. Efficient meningococcal vaccines with good safety profiles are available. Including meningococcal vaccines in national immunisation programmes should be considered in all European countries, and surveillance of N. meningitidis strains should be continued.
More Related Videos
Related Concept Videos
Vaccinations
Microorganisms in Medicine and Therapeutics
Healthcare Associated Infections II: Preventive Measures
The best practices for preventing healthcare-associated infections include hand hygiene, patient risk...

